Profile
Maritza C.
McIntyre is an Independent Director at Gensight Biologics SA since 2019.
She is also a Director at Standards Coordinating Body, an Executive VP-Regulatory Affairs & Product at Bamboo Therapeutics, Inc., and the President of Advanced Therapies Partners LLC.
Previously, McIntyre worked as an Executive Director-Gene Therapy Product Lead at Pfizer Inc. from 2016 to 2017.
She also served as a Director of US Regulatory Affairs at Bavarian Nordic A and as a Director at the American Society of Gene & Cell Therapy.
Additionally, McIntyre held positions as a Vice President-Regulatory Affairs at NanoCor Therapeutics, Inc. and REGENXBIO, Inc. She worked as a Senior Consultant at Biologics Consulting Group, Inc. and as the Chief-Gene Therapy Branch at the US Food & Drug Administration.
McIntyre was also the Chief Development Officer at StrideBio, Inc. McIntyre completed her undergraduate studies at Wayne State University (Michigan) and earned a doctorate degree from The University of Chicago.
Maritza McIntyre active positions
| Companies | Position | Start |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Director/Board Member | 2019-06-10 |
Advanced Therapies Partners LLC | President | - |
Standards Coordinating Body
Standards Coordinating Body The Standards Coordinating Body is a nonprofit organization focused on accelerating the development, awareness, and implementation of standards and best practices in regenerative medicine, including gene, cell, and advanced therapies. The private company is based in Gaithersburg, MD. It engages stakeholders such as government agencies, researchers, manufacturers, clinicians, and regulators to identify, prioritize, and advance standards that improve the safety, quality, efficacy, and availability of regenerative medicine products. The organization facilitates collaborative project working groups that develop feasibility studies, standards drafts, white papers, and coordinate data generation activities in areas like cell-based drug discovery, cell therapy, gene therapy, and tissue engineering. It offers specialized training programs on FDA-recognized ISO cell counting standards, including online and in-person courses, and provides resources such as an interactive database for exploring current and developing standards and educational materials. | Director/Board Member | - |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops gene therapies for rare neuromuscular and central nervous system diseases | General Counsel | - |
Former positions of Maritza McIntyre
| Companies | Position | End |
|---|---|---|
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Corporate Officer/Principal | 2021-10-31 |
| PFIZER INC. | Corporate Officer/Principal | 2016-12-31 |
NanoCor Therapeutics, Inc.
NanoCor Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology products and services | Public Communications Contact | - |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Director/Board Member | - |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
Training of Maritza McIntyre
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
NanoCor Therapeutics, Inc.
NanoCor Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology products and services | Health Technology |
Biologics Consulting Group, Inc.
Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides regulatory and product development advice for drugs and device products | Commercial Services |
REGENXBIO, Inc.
REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Wayne State University (Michigan)
Wayne State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bavarian Nordic A/S
Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Gensight Biologics SA
Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops gene therapies for rare neuromuscular and central nervous system diseases | Health Technology |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
Standards Coordinating Body
Standards Coordinating Body The Standards Coordinating Body is a nonprofit organization focused on accelerating the development, awareness, and implementation of standards and best practices in regenerative medicine, including gene, cell, and advanced therapies. The private company is based in Gaithersburg, MD. It engages stakeholders such as government agencies, researchers, manufacturers, clinicians, and regulators to identify, prioritize, and advance standards that improve the safety, quality, efficacy, and availability of regenerative medicine products. The organization facilitates collaborative project working groups that develop feasibility studies, standards drafts, white papers, and coordinate data generation activities in areas like cell-based drug discovery, cell therapy, gene therapy, and tissue engineering. It offers specialized training programs on FDA-recognized ISO cell counting standards, including online and in-person courses, and provides resources such as an interactive database for exploring current and developing standards and educational materials. | |
Advanced Therapies Partners LLC |
- Stock Market
- Insiders
- Maritza McIntyre
















